Your search returned 6 results.

Results
	1.	A 46 year old man with carcinoma of unknown primary site. [electronic resource] by Liniker, E Al-Jilaihawi, S Propper, D Slater, S Pacey, S Producer: 20121029 In: BMJ (Clinical research ed.) vol. 345 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model. [electronic resource] by Wright, K E Liniker, E Loizidou, M Moore, C Macrobert, A J Phillips, J B Producer: 20090904 In: British journal of cancer vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009-2010). [electronic resource] by Liniker, E Harrison, M Weaver, J M J Agrawal, N Chhabra, A Kingshott, V Bailey, S Eisen, T G G Corrie, P G Producer: 20140117 In: British journal of cancer vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma. [electronic resource] by Liniker, E Menzies, A M Kong, B Y Cooper, A Ramanujam, S Lo, S Kefford, R F Fogarty, G B Guminski, A Wang, T W Carlino, M S Hong, A Long, G V Publication details: Oncoimmunology In: Oncoimmunology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272. [electronic resource] by Minami, Y Shimamura, T Shah, K LaFramboise, T Glatt, K A Liniker, E Borgman, C L Haringsma, H J Feng, W Weir, B A Lowell, A M Lee, J C Wolf, J Shapiro, G I Wong, K-K Meyerson, M Thomas, R K Producer: 20070906 In: Oncogene vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy. [electronic resource] by Bowyer, S Prithviraj, P Lorigan, P Larkin, J McArthur, G Atkinson, V Millward, M Khou, M Diem, S Ramanujam, S Kong, B Liniker, E Guminski, A Parente, P Andrews, M C Parakh, S Cebon, J Long, G V Carlino, M S Klein, O Producer: 20170602 In: British journal of cancer vol. 114 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)